Advertisement

Topics

Merck Announces Pricing of Any and All Tender Offers

14:00 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, announced today the pricing of the previously announced offers to purchase (collectively, the “Offers”) any and all of the outstanding not...

Other Sources for this Article

Merck
Media:
Claire Gillespie, 267-305-0932
or
Investors:
Amy Klug, 908-740-1898

NEXT ARTICLE

More From BioPortfolio on "Merck Announces Pricing of Any and All Tender Offers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...